TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q9)Sep 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -24.48%46.86B | -27.87%180.74B | -34.56%62.04B | 12.17%250.57B | 56.40%94.8B | 21.04%223.38B | 18.52%60.62B | --14.99B | 22.20%184.55B | --62.9B |
Operating income | -24.48%46.86B | -27.87%180.74B | -34.56%62.04B | 12.17%250.57B | 56.40%94.8B | 21.04%223.38B | 18.52%60.62B | 22.20%184.55B | ||
Cost of sales | 22.70%-37.21B | 23.98%-150.15B | 35.51%-48.14B | -18.40%-197.53B | -70.30%-74.66B | -27.83%-166.83B | -23.86%-43.84B | ---- | -30.22%-130.52B | ---- |
Operating expenses | 22.70%-37.21B | 23.98%-150.15B | 35.51%-48.14B | -18.40%-197.53B | -70.30%-74.66B | -27.83%-166.83B | -23.86%-43.84B | -30.22%-130.52B | ||
Gross profit | -30.64%9.64B | -42.34%30.58B | -31.01%13.9B | -6.19%53.04B | 20.09%20.15B | 4.65%56.54B | 6.53%16.78B | 6.37%54.03B | ||
Selling expenses | 20.70%-1.91B | 1.40%-5.26B | -11.85%-2.41B | 2.30%-5.34B | 7.49%-2.16B | -8.54%-5.46B | -36.07%-2.33B | ---- | -24.77%-5.03B | ---- |
Administrative expenses | 20.67%-2.28B | 19.01%-5.5B | 29.73%-2.88B | 37.21%-6.79B | 12.71%-4.09B | -48.35%-10.82B | -61.72%-4.69B | ---- | -11.86%-7.29B | ---- |
Revaluation surplus | -4.82%1.87B | -24.97%1.97B | 29.62%1.96B | -4.37%2.63B | -39.89%1.51B | 19.69%2.75B | 43.41%2.52B | ---- | -43.84%2.3B | ---- |
-Changes in the fair value of investment property | -19.65%1.5B | -30.31%2.01B | 18.29%1.87B | 1.33%2.89B | -38.09%1.58B | 23.41%2.85B | 47.01%2.55B | ---- | -38.17%2.31B | ---- |
-Changes in the fair value of derivative financial instruments | 281.00%368.92M | 84.27%-40.92M | 253.23%96.83M | -154.66%-260.14M | -120.38%-63.19M | -654.89%-102.15M | -222.01%-28.68M | ---- | -103.83%-13.53M | ---- |
Operating interest expense | ---- | 5.51%-149.48M | ---- | -8.15%-158.19M | -4.33%-83.55M | -38.03%-146.27M | -9.68%-80.08M | ---- | -38.06%-105.97M | ---- |
Special items of operating profit | 131.62%1.14B | 49.76%1.54B | 163.53%490.91M | -44.19%1.03B | -80.92%186.29M | 53.60%1.84B | 815.77%976.15M | ---- | 235.42%1.2B | ---- |
Operating profit | -23.63%8.45B | -47.80%23.18B | -28.68%11.07B | -0.66%44.4B | 17.79%15.51B | -0.87%44.69B | 1.91%13.17B | 1.07%45.09B | ||
Financing cost | -0.17%-77.18M | ---- | ---77.05M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | 53.09%412.94M | -68.30%134.84M | -0.35%269.73M | -68.34%425.32M | 4,126.64%270.67M | 94.37%1.34B | -98.78%6.4M | ---- | 18.00%691.26M | ---- |
Share of profit from joint venture company | -69.20%343.95M | 42.45%1.42B | 682.80%1.12B | -37.30%996.15M | -79.44%142.68M | 168.94%1.59B | 271.51%693.97M | ---- | -22.89%590.8M | ---- |
Earning before tax | -26.22%9.13B | -46.03%24.73B | -22.31%12.37B | -3.79%45.82B | 14.82%15.93B | 2.71%47.63B | 1.72%13.87B | 0.89%46.37B | ||
Tax | 30.00%-2.16B | 41.56%-7.6B | 38.95%-3.08B | 17.93%-13B | -34.80%-5.04B | 9.65%-15.84B | 23.20%-3.74B | ---- | 9.68%-17.53B | ---- |
After-tax profit from continuing operations | -24.96%6.97B | -47.80%17.13B | -14.59%9.3B | 3.25%32.82B | 7.44%10.88B | 10.22%31.79B | 15.57%10.13B | 8.62%28.84B | ||
Earning after tax | -24.96%6.97B | -47.80%17.13B | -14.59%9.3B | 3.25%32.82B | 7.44%10.88B | 10.22%31.79B | 15.57%10.13B | 1.69B | 8.62%28.84B | 10.31B |
Minority profit | -10.36%1.11B | -49.38%4.28B | -63.64%1.24B | 6.63%8.46B | 25.58%3.4B | -10.23%7.93B | 11.69%2.71B | ---- | 7.58%8.84B | ---- |
Profit attributable to shareholders | -27.21%5.87B | -47.25%12.85B | 7.73%8.06B | 2.13%24.36B | 0.82%7.48B | 19.26%23.85B | 17.05%7.42B | 9.08%20B | ||
Basic earnings per share | -31.69%0.899 | -49.26%2.07 | 3.79%1.316 | 0.74%4.08 | 0.71%1.268 | 18.77%4.05 | 16.68%1.259 | 8.95%3.41 | ||
Diluted earnings per share | -31.42%0.897 | -49.14%2.06 | 4.39%1.308 | 1.50%4.05 | 1.21%1.253 | 19.46%3.99 | 16.90%1.238 | 8.79%3.34 | ||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.